GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (MEX:ATAI) » Definitions » Dividend-Payout-to-FFO

ATAI Life Sciences NV (MEX:ATAI) Dividend-Payout-to-FFO


View and export this data going back to 2022. Start your Free Trial

What is ATAI Life Sciences NV Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


ATAI Life Sciences NV (MEX:ATAI) Business Description

Traded in Other Exchanges
Address
Wallstraße 16, Berlin, BB, DEU, 10179
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.